Magnolia Medical Technologies Revenue and Competitors
Estimated Revenue & Valuation
- Magnolia Medical Technologies's estimated annual revenue is currently $33.6M per year.
- Magnolia Medical Technologies's estimated revenue per employee is $251,000
- Magnolia Medical Technologies's total funding is $117.3M.
Employee Data
- Magnolia Medical Technologies has 134 Employees.
- Magnolia Medical Technologies grew their employee count by 10% last year.
Magnolia Medical Technologies's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Associate VP Clinical Strategy and Customer Relations | Reveal Email/Phone |
2 | CEO & Co-Founder | Reveal Email/Phone |
3 | Senior Area VP Sales | Reveal Email/Phone |
4 | Sr VP Operations and Product Develppment | Reveal Email/Phone |
5 | Area VP Sales | Reveal Email/Phone |
6 | VP, Marketing | Reveal Email/Phone |
7 | Director Strategic Accounts | Reveal Email/Phone |
8 | Business Director | Reveal Email/Phone |
9 | Business Director | Reveal Email/Phone |
10 | Business Director | Reveal Email/Phone |
Magnolia Medical Technologies Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.9M | 39 | 117% | $14.9M | N/A |
#2 | $44.9M | 143 | -30% | $211.3M | N/A |
#3 | $54M | 172 | 11% | $35.5M | N/A |
#4 | $4.3M | 17 | -19% | N/A | N/A |
#5 | $18.3M | 73 | N/A | N/A | N/A |
#6 | $8.3M | 33 | 6% | N/A | N/A |
#7 | $81.1M | 323 | 17% | N/A | N/A |
#8 | $7M | 28 | -12% | N/A | N/A |
#9 | $204.8M | 816 | 3% | N/A | N/A |
#10 | $6.3M | 50 | 25% | $27.5M | N/A |
What Is Magnolia Medical Technologies?
Magnolia Medical Technologies develops innovative medical products that achieve predictable, high-quality outcomes. The company's first product SteriPath is the only clinically proven blood culture collection solution that maintains consistent, sustainable contamination rates as low as 0.2%. By enabling providers to consistently execute best practices, SteriPath virtually eliminates false positives--mitigating previously unavoidable clinical and financial risks, reducing unnecessary treatment, and ensuring optimal patient outcomes.
keywords:N/A
$117.3M
Total Funding
134
Number of Employees
$33.6M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Magnolia Medical Technologies News
SEATTLE, April 6, 2022 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device...
SEATTLE, July 29, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination1 for sepsis testing, announces the commercial availability of its new Steripath® Micro Initial Specim ...
SEATTLE, June 9, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc., inventors of Steripath®, the only FDA 510(k)-cleared device platform indicated to reduce blood culture contamination,1 announced today continued clinical efficacy data supporting multiple, peer-reviewed clinical studies ...
SEATTLE, April 14, 2021 /PRNewswire/ -- Magnolia Medical Technologies, Inc. recently launched a new multi-media advertising campaign to promote the benefits of the Steripath® Initial Specimen Diversion Device® (ISDD®) platform. Built around the theme "Diverted", the campaign underscores the c ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $36.2M | 134 | 8% | N/A |
#2 | N/A | 134 | 9% | N/A |
#3 | $23.5M | 134 | 19% | N/A |
#4 | $29.5M | 134 | -1% | N/A |
#5 | $23M | 135 | -32% | $70.2M |